1. Introduction {#s0005}
===============

Late-life depression (LLD) and amnestic mild cognitive impairment (aMCI) are highly prevalent neuropsychiatric syndromes that often coexist in the elderly ([@bb0325]). LLD is associated with poorer treatment response and outcomes of comorbid medical disorders, increased mortality risk, caregiver burden and functional disability ([@bb0025]). LLD and aMCI, alone or in combination, also increase the risk of developing Alzheimer\'s disease (AD) ([@bb0135; @bb0230; @bb0245]). Although LLD and aMCI are considered distinct clinical phenotypes, it is unclear if shared or distinct pathogenic mechanisms are involved in these disorders when they occur alone versus coexists. Neuroimaging investigations have provided unique insights into the hippocampal involvement in LLD and aMCI. The hippocampus is central to the episodic memory formation and has been the focus of AD research for several decades ([@bb0110]). This brain region is also vital to the dorsal-cognitive system of the mood regulation circuitry (MRC) and is implicated in the neuroanatomical model of LLD ([@bb0025]). Hippocampal structural abnormalities were evident in individuals with LLD and aMCI, and those with smaller volumes may be at a greater risk for subsequent cognitive decline ([@bb0055; @bb0195; @bb0280; @bb0300; @bb0320]).

Positron emission tomography and functional magnetic resonance imaging (fMRI) methods have unraveled the functional neuroanatomy of LLD and aMCI. The frontostriatal dysfunction commonly described in LLD is persistent and may only partially improve with antidepressant treatment ([@bb0015; @bb0020]). However, the extent of MTL-based neural circuit abnormalities associated with LLD remains unclear. In contrast, altered hippocampal activation to various memory paradigms has been demonstrated in aMCI ([@bb0115; @bb0225]). These fMRI experiments have clarified task-dependent MTL activations or deactivations in LLD and aMCI, but important challenges remain. First, differences in task performance between cognitively healthy and patients with LLD and/or aMCI may complicate data interpretation. Second, neuroimaging investigations have failed to examine the mechanistic similarities and differences between LLD and aMCI, when these conditions occur alone or in combination. Third, while traditional fMRI studies provide critical information into the memory task-dependent differences of specific brain regions, they offer limited conclusions as to how different functionally related structures are interconnected in healthy and diseased states. This is pertinent because LLD and aMCI have been hypothesized as disconnection syndromes affecting the distributed brain networks ([@bb0115; @bb0355]).

The resting-state functional connectivity MRI (R-fMRI) technique is based on the observation that temporal interregional correlations of spontaneous low-frequency blood oxygenation level-dependent fluctuations exist between functionally coupled but spatially segregated brain regions in the absence of a task ([@bb0065; @bb0070; @bb0125]). The brain\'s organization into multiple, functionally connected networks that subserve various behavioral functions have been identified using the R-fMRI method in normal and pathological conditions, including depression, and preclinical and clinical AD ([@bb0005; @bb0035; @bb0080; @bb0095; @bb0145; @bb0155; @bb0160; @bb0165; @bb0220; @bb0275; @bb0295; @bb0330]). The hippocampus is central to the episodic memory network (EMN) and is densely interconnected with functionally related limbic and neocortical regions ([@bb0110]). The hippocampus is also critical for the brain\'s interactive and integrative potential to bring together emotion and memory functions ([@bb0180]). A left--right asymmetry in the hippocampal volumetric and functional connectivity alterations have been reported in LLD, aMCI and/or early AD ([@bb0300; @bb0320; @bb0340]). Greater decreases in hippocampal subregional functional connectivity were associated with episodic memory declines in persons with aMCI ([@bb0050]). In contrast, others have demonstrated increased and decreased MTL connectivity with aMCI ([@bb0105; @bb0345]). Furthermore, predominantly diminished functional connectivity in the hippocampal networks has been demonstrated in AD ([@bb0040; @bb0340]). Regardless, how the disruption in the episodic memory system unfolds in LLD and aMCI, when these disorders appear independently or co-occur remains to be understood.

The primary objective of this study was to investigate the main and interactive effects of LLD and aMCI on the left and right hippocampal functional connectivity in the elderly. We hypothesized that distinct hippocampal functional connectivity (HFC) abnormalities will be seen in LLD and aMCI groups, whereas significant interactive effects will be found between LLD and aMCI involving regions critical for emotional regulation and multidomain cognitive functions. Furthermore, we hypothesize that the comorbid group will predominantly drive the HFC disruptions in the interactive regions. As a secondary objective, we also determined the neural correlates of the main and interactive effects of depressive symptoms and episodic memory performance on the HFC networks across all subjects.

2. Material and methods {#s0010}
=======================

2.1. Participants {#s0015}
-----------------

Seventy-two subjects aged 60 and older (cognitively healthy, LLD \[n = 18\]; aMCI alone \[n = 17\]; LLD with aMCI \[n = 12\]; and cognitively normal, nondepressed controls \[n = 25\]) participated in this study ([@bb0375]). All patients diagnosed as having clinically significant depression and/or aMCI were recruited from the Geriatric Psychiatry and Memory Disorders Clinics at the Medical College of Wisconsin. Control subjects were recruited from the community through advertisements. All participants provided written informed consent according to the institution\'s guidelines for human subject protection.

Study participants received detailed clinical and neuropsychiatric assessments. The core neuropsychological battery administered to all participants included the (1) Mini-Mental State Examination (MMSE) (all subjects had to score ≥ 24); (2) Mattis Dementia Rating Scale-2 (MDRS-2) (age- and education-corrected MOANS-scaled score of ≥ 5) ([@bb0205]); (3) education-adjusted Logical Memory II Delayed paragraph recall (LMII-DR) subscale from the Wechsler Memory Scale-Revised ([@bb0350]); (4) Physical Self Maintenance Scale/Instrumental Activities of Daily Living (PSMS/IADL) ([@bb0185]); (5) 30-item Yesavage Geriatric Depression Scale (GDS) ([@bb0380]); (6) Diagnostic assessment for Axis 1 disorders including the depression module from the Structured Clinical Interview for DSM IV ([@bb0120]); and (7) Hamilton Anxiety Scale (HAM-A). All participants scored ≤ 4 on the modified Hachinski ischemic scale (HIS). GDS was repeated again on the day of the imaging scan visit. Clinical assessment findings were reviewed during the weekly multidisciplinary consensus conferences.

Thirty participants met criteria for clinically significant depression according to the Structured Clinical Interview for DSM-IV TR Axis 1 disorders, research version, non-patient edition \[SCID\]. Eighteen participants with clinically significant depression were included in the cognitively normal LLD group (major depression: n = 17, and minor depression: n = 1). All participants had a GDS score of 10 or above, MMSE ≥ 26, PSMS ≤ 6 and IADL ≤ 9, score above the education-adjusted cutoff on the LMII-DR (Delayed recall score \> 8 for 16 or more years of education or score \> 4 for 8--15 years of education).

All participants who also met aMCI criteria with significant depression (n = 12) were included in the comorbid LLD and aMCI group (major depression: n = 11, dysthymic disorder: n = 1). Antidepressant doses in both depressed groups had to be at stable doses for at least two weeks before study enrollment and until completion of the study procedures.

Amnestic mild cognitive impairment (aMCI) was operationally defined according to the established criteria ([@bb0360]): (1) subjective report of cognitive decline; (2) objective cognitive impairment that includes scoring 1.5 SD below on memory measures; (3) intact ADLs and relatively preserved IADLs; and (4) no dementia. For meeting criteria for objective cognitive impairment, participants had to score below the education-adjusted cutoff on the LMII-DR (i.e., ≤ 8 for 16 or more years of education, and ≤ 4 for 8--15 years of education), and score below 1.5 SD below the mean on one or more subscales (one of the impairments had to be memory) of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) ([@bb0255]), Behavioral Dyscontrol scale or the Boston Naming Test. Subjects who met the aMCI criteria and did not have clinically significant depression (n = 17) were included in the nondepressed aMCI group.

The control group consisted of participants who did not meet criteria for cognitive or Axis 1 psychiatric disorders and were not on psychoactive medications (n = 25).

Exclusion criteria included past or current history of concurrent Axis 1 psychiatric disorders, such as psychotic or bipolar disorders; alcohol or substance abuse/dependence during the past five years; active suicidality; MMSE scores \< 24; history of neurological diseases, including Parkinson\'s disease, dementia, multiple sclerosis, seizures, or stroke; head injury with loss of consciousness; MRI contraindications and unstable medical conditions.

2.2. MRI acquisition {#s0020}
--------------------

Imaging was performed using a whole-body 3T Signa GE scanner (Waukesha, WI) with a standard transmit-receive head coil. During the resting-state acquisitions, no cognitive tasks were performed and the participants were instructed to close their eyes, relax and stay awake. Sagittal R-fMRI data sets of the whole brain were obtained in 8 min with a single-shot gradient echo--echo planar imaging pulse sequence. The R-fMRI parameters were: TE = 25 ms, TR = 2000 ms, flip angle of 90°; number of slices = 36; slice thickness = 4 mm, matrix size = 64 × 64 and field of view (FOV) = 240 × 240 mm. High-resolution 3D spoiled gradient-recalled echo (SPGR) axial images were acquired for anatomical reference. The parameters were: TE/TR/TI of 4/10/450 ms, flip angle of 12°, number of slices = 144, slice thickness = 1 mm, matrix size = 256 × 192 and FOV = 240 × 240 mm.

2.3. Structural and functional connectivity MRI data processing {#s0025}
---------------------------------------------------------------

### 2.3.1. R-fMRI preprocessing {#s0030}

R-fMRI data analyses were carried out by using AFNI software (<http://afni.nimh.nih.gov/afni>) and MATLAB programs (The MathWorks Inc., Natick, MA). The preprocessing steps are identical to the one followed in our previous publications ([@bb0145; @bb0155; @bb0200; @bb0365; @bb0370]). The spikes in the raw R-fMRI data were removed (3dDespike); motion correction was performed by volume registration on the R-fMRI data (*3dvolreg*); and detrending was carried out to remove Legendre polynomials (*3dDetrend*). Possible contamination from the signals in white matter, cerebrospinal fluid, the six-motion vectors, physical noise (cardiac and respiratory signals) and global signal were regressed out from each voxel time series ([@bb0060; @bb0100; @bb0130; @bb0140; @bb0240; @bb0270]). A band-pass filter was applied to isolate spontaneous low-frequency fluctuations within the range of 0.015 Hz and 0.1.

### 2.3.2. Hippocampal functional connectivity analysis {#s0035}

The left and the right hippocampus regions of interest (ROI) were manually drawn on the coronal slices, with reference to the sagittal and axial slices, and on the structural images of individual subject, as described previously ([@bb0270]), using AFNI software, after being blinded to the participants\' demographics and clinical characteristics. The various processing steps were described previously ([@bb0145; @bb0155; @bb0150; @bb0370]). Briefly, the time courses of these hippocampal voxels were cross-correlated to the time courses of all the voxels in the brain mask, and the Pearson correlation coefficients (*r*) were obtained, The cross-correlation coefficients (*r*) were converted to *m* scores according to Fisher\'s *z* transformation for normal distribution \[m = 0.5ln(1 + r) / (1 − r)\] ([@bb0385]). These voxelwise *m* values were spatially transformed to the Talairach template coordinates (*adwarp*), resampled to 2-mm isotropic voxels, and smoothed with a Gaussian kernel (6-mm full-width half-maximum) using AFNI software (*3dmerge*). The end result was the left (L) and the right (R) HFC network maps for each participant.

### 2.3.3. Structural image processing {#s0040}

Optimized voxel-based morphometry (VBM) analysis was performed, using the VBM8 toolbox in SPM8 (<http://www.fil.ion.ucl.ac.uk/spm/software/spm8>). The individual T1-weighted images for all subjects were segmented into gray matter (GM), white matter (WM) and cerebral spinal fluid (CSF) and the summation of them comprised the intracranial volume (ICV). The segmented GM volumes were then normalized, smoothed at 6-mm full-width half-maximum, and resampled to 2-mm isotropic voxels for further analyses. The voxelwise GM volume was controlled as a covariate in the statistical analyses.

2.4. Statistical analysis {#s0045}
-------------------------

### 2.4.1. Subject characteristics {#s0050}

Group comparisons for demographic information (age and education), except gender (χ^2^ test) were compared using analysis of variance (ANOVA) (significance set at *p* \< 0.05 to avoid false negative rate). Neuropsychological measurements were compared by ANCOVA, after controlling for age, gender and education (significance threshold at *p* \< 0.0045, Bonferroni corrected) (SPSS 18.0; SPSS Inc., Chicago, IL). The sources of the differences between the means of the four groups were examined by post-hoc Fisher\'s least significant difference test for demographics; and the post-hoc Bonferroni-corrected tests were performed when appropriate for neuropsychological measures.

### 2.4.2. Group-level HFC analysis {#s0055}

Individual HFC maps for each subject were analyzed with a random-effects one-sample *t* test to identify voxels, showing a significant positive or negative correlation with the seed time series, and the patterns of left and right HFC network for four groups were separately obtained after controlling the effects of age, gender, education and voxelwise GM volume (3dttest^++^, *p* \< 0.01, corrected with AlphaSim, cluster size \> 1042 mm^3^). To examine the group difference of the LHFC and RHFC networks across all subjects, voxelwise 2 (depression) × 2 (cognitive impairment) ANCOVA was separately performed after controlling for age, gender, education and GM volume (3dRegAna, AFNI) (*p* \< 0.05, corrected with AlphaSim, cluster size \> 4048 mm^3^).

### 2.4.3. Behavioral significance {#s0060}

To investigate the behavioral significance of the left and right HFC networks, multiple linear regression analyses were employed (*3dRegAna*, AFNI) between the individual HFC maps and the GDS and LMII-DR scores across the four groups, using the following equation:$$m_{i} = \beta_{0} + \beta_{1}{GDS} + \beta_{2}{LMII}‐{DR} + \beta_{3}{GDS} \times {LMII}‐{DR} + \beta_{4}{Age} + \beta_{5}{Gen} + \beta_{6}{Edu} + \beta_{7}{GM} + \beta_{8}G0 + \beta_{9}G1 + \beta_{10}G2 + \beta_{11}G3 + \epsilon$$where *m~i~* is the *m* value of *i*th voxel across group subjects and *β*~0i~ is the intercept of straight line fit of the *i*th group in the model. *β*~1~, *β*~2~, and *β*~3~ are the effects of GDS scores, memory scores (LMII-DR), and interaction of GDS and memory scores on the functional connectivity strength of *i*th voxel within HFC network, respectively. *β*~4~, *β*~5~, *β*~6~, and *β*~7~ are the effects of age, gender, education, and GM volume as covariates of no interest in the above model. G is the group variable in the model; specifically, *β*~8~G0 = 1 if not LLD and not aMCI, 0 otherwise; *β*~9~G1 = 1 if LLD and not aMCI, 0 otherwise; *β*~10~G2 = 1 if aMCI and not LLD, 0 otherwise; *β*~11~G3 = 1 if LLD and aMCI, 0 otherwise. The voxelwise multiple linear regression map was also generated to examine the main and interactive effects of GDS and LMII-DR on the bilateral HFC networks (AlphaSim correction, *p* \< 0.05, cluster size \> 4048 mm^3^).

3. Results {#s0065}
==========

3.1. Demographic and neuropsychological characteristics {#s0070}
-------------------------------------------------------

Significant age and neuropsychiatric measure differences were found; post-hoc analyses revealed the source of differences ([Table 1](#t0005){ref-type="table"}). One-sample patterns of the left and right HFC networks in the four groups are presented in [Figs. S1 and S2](#f0025 f0030){ref-type="fig"}.

Significant age and neuropsychiatric measure differences were found; post-hoc analyses revealed the source of differences ([Table 1](#t0005){ref-type="table"}). One-sample patterns of the left and right HFC networks in the four groups are presented in Figs. S1 and S2.

3.2. Neuroimaging data {#s0075}
----------------------

### 3.2.1. Main effects of LLD and cognitive impairment on the HFC networks {#s0080}

#### 3.2.1.1. Left HFC network {#s0135}

The depressed groups demonstrated increased left HFC in the bilateral PCC, and right DMPFC, and decreased anticorrelation (with a reversal of pattern to positive) in the right DLPFC, relative to the nondepressed groups. The mild cognitive impairment (CI) groups showed consistently decreased positive and negative HFC in the bilateral dorsolateral prefrontal cortex (DLPFC), dorsomedial prefrontal cortex (DMPFC), inferior parietal cortex (IPC), retrosplenial cortex (RSC); postcentral gyrus and posterior middle temporal gyrus (pMTG) on the left; and right dorsal anterior cingulate cortex (dACC) and superior parietal cortex (SPC). In bilateral DMPFC, and left postcentral gyrus, IPC and pMTG, there is a reversal of pattern from positive to negative correlation in the CI group, relative to non-CI group. Similarly, there is a reversal of negative to positive correlation pattern in the CI group in the right IPC, dACC and SPC compared to the non-CI subjects ([Fig. 1](#f0005){ref-type="fig"}).

#### 3.2.1.2. Right HFC network differences {#s0140}

The main effects of depression on the RHFC network included increased HFC in the bilateral thalamus, left hippocampus and right lentiform nucleus; and decreased anticorrelated hippocampal connectivity (with a reversal of pattern to positive correlation) in the bilateral middle occipital gyrus (MOG), and in the left DLPFC and dorsal striatum (caudate and putamen). The main effects of the CI (vs. the non-CI) groups on the RHFC network included consistently diminished positive and negative HFC in bilateral anterior temporal pole (aTP) and IPC; left ventrolateral prefrontal cortex (vlPFC), parahippocampal gyrus (PHG), and pMTG; and right inferior temporal cortex (ITC). The patterns are reversed in all but aTP in the CI groups, relative to non-CI subjects ([Fig. 2](#f0010){ref-type="fig"}).

### 3.2.2. Interactive effects of LLD and cognitive impairment on the HFC networks {#s0085}

The interactive effects of LLD and CI were only identified on the RHFC network and included the ventromedial prefrontal cortex (vmPFC) and MOG bilaterally, left dACC and right DLPFC/dACC cluster ([Fig. 3](#f0015){ref-type="fig"}).

### 3.2.3. The effects of depressive symptoms and memory deficits on the hippocampal networks {#s0090}

The GDS scores positively correlated with the left HFC network in the DMPFC and inferior temporal cortex (ITC) bilaterally; negatively correlated with the left HFC network in the hippocampus/PHG bilaterally, and left DLPFC. The GDS scores positively correlated with the right HFC in the bilateral DMPFC and ITC, right pMTG, and negatively correlated in the bilateral DLPFC, vmPFC, and hippocampus/PHG, left IFG, and right IPC and anterior insula/frontal operculum (aI/fO) ([Fig. 4](#f0020){ref-type="fig"} top row).

LMII-DR scores positively correlated with the left HFC network in the left thalamus, and negatively correlated in the bilateral precuneus/posterior central gyrus (Pcu/PostCG). LMII-DR scores positively correlated with the RHFC network in the left DMPFC and right ITC and negatively correlated in the amygdala/PHG (Amy/PHG) ([Fig. 4](#f0020){ref-type="fig"} middle row).

The GDS--LMII-DR interactions on the left HFC network were found in the left aI/fO, and in the right HFC network were demonstrated in DMPFC, DLPFC and IPC on the right ITC ([Fig. 4](#f0020){ref-type="fig"} bottom row).

4. Discussion {#s0095}
=============

This study demonstrates that the main and interactive effects of LLD and aMCI are present in the hippocampus-centered EMN in older adults free of dementia. Both increased and decreased HFC with several cortical and subcortical structures involved in emotion processing were related to LLD. aMCI was associated with globally diminished connectivity in cortical and MTL regions. Significant LLD and aMCI interactions on the right HFC networks were seen in regions critical for mood regulation and higher-order cognitive functions. We also demonstrated that main and interactive effects of depressive symptoms and episodic memory deficits on the HFC networks exist in the elderly, which is consistent with our prior observations.

4.1. Main effects of depression on the hippocampal functional brain networks {#s0100}
----------------------------------------------------------------------------

In the left hippocampal networks, we found increased functional connections with the default mode network (DMN) regions. These findings are consistent with the recent observations in LLD of increased cortical glucose metabolism and DMN functional connectivity ([@bb0035; @bb0045; @bb0305]). Similar functional connectivity patterns and hyperactivation in the DMN and MTL structures to an emotional regulation paradigm have been demonstrated in younger depressed adults ([@bb0285; @bb0295]). Sustained increased activation within the DMN and EMN structures has been related to greater ruminative thought patterns and severe depressive episodes in major depression.

While LLD was associated with increased right hippocampal network connections with the thalamus, basal ganglia and MTL, diminished hippocampal-DLPFC connectivity was seen. These regions are crucial components of the limbic-cortical-striato-pallido-thalamic circuits implicated in the neurobiological model of depression. The prolonged processing of negative emotions seen in depression is maintained by the impairments of the top-down cognitive control by the DLPFC over the subcortical and limbic structures. Individuals with depression show higher awareness to the negative emotional stimuli, which is first relayed to the thalamus, and subsequently transferred and interpreted by the MTL structures ([@bb0210; @bb0250]). The increased hippocampal connections with the subcortical structures, and decreased HFC-DLPFC functional connectivity found here are consistent with this theory. Moreover, decreased DLPFC connectivity and increased subcortical connectivity are seen in LLD ([@bb0035]). We also identified diminished right hippocampal connections in the dorsal striatum with a reversal from negative (or anticorrelated) to positive connectivity values in the LLD groups ([Fig. 2](#f0010){ref-type="fig"}). The increased periventricular and basal ganglia white matter hyperintensities and decreased structural integrity of the adjacent tracts that is reported in LLD may have contributed to these findings ([@bb0010; @bb0330]). On the contrary, increased dorsal striatal connectivity is reported in LLD, though it is unclear whether contamination from the nuisance variables (white matter, CSF, cardiac, respiratory and global signals) was regressed out in that study ([@bb0165]). A few other possibilities may also explain the discrepant findings. The selection of different predefined ROIs and R-fMRI methods in LLD studies makes direct comparisons difficult. Also, several seed-based R-fMRI studies have limited the analyses to only positive connectivity differences, which may have failed to identify the shifts of connectivity values from negative to positive patterns. While some argue that the negative correlations in R-fMRI analyses are artificially induced by global signal removal, recent evidence has demonstrated a biological basis to the anticorrelated connectivity ([@bb0130; @bb0155; @bb0275; @bb0290; @bb0370]).

4.2. Main effects of cognitive impairment on hippocampal functional brain networks {#s0105}
----------------------------------------------------------------------------------

Our findings of diminished HFC in the frontal, parietal, temporal and MTL regions in aMCI patients are consistent with the literature ([@bb0050]). The hippocampus is extensively interconnected with neocortical association areas and temporal lobe structures. These regions are essential for episodic memory, semantic processing, self-monitoring and related social cognitive functions, mood regulation and attentional switching, which are often impaired in aMCI. Previously, decreased hippocampal functional connections with similar brain regions have been reported in patients with aMCI and early AD, and MTL functional disruptions may be indicative of the incipient AD ([@bb0310; @bb0340; @bb0345]). Also, the left and right HFC differences did not mirror each other, which are similar to the previous aMCI and early AD studies ([@bb0340; @bb0345]). On the contrary, we found no regions with increased functional connections to the hippocampus as previously reported in one study ([@bb0345]). Interestingly, baseline increases were followed by longitudinal decreases in the left and right HFC in aMCI patients, suggesting that the initially observed enhanced connections are a compensatory process ([@bb0345]). Moreover, while increased functional connectivity within the MTL subregions was seen in aMCI patients, the MTL connections with the nodes in the DMN and fronto-parietal cortical system were decreased in aMCI in another recent investigation, the latter findings are consistent with our data ([@bb0105]). Additional cross-sectional and longitudinal studies are needed to gain in-depth understanding of the dynamic hippocampal functional connectivity alterations in the normal elderly and aMCI patients.

4.3. Interactive effects of depression and cognitive impairment on HFC networks {#s0110}
-------------------------------------------------------------------------------

Significant LLD--aMCI interactions in the hippocampal functional network level were found in the default mode, cognitive control and salience network regions critical for emotion processing, episodic memory and executive function processes. The effects of LLD and aMCI comorbidity on the HFC were greater than the independent effects of these disorders, suggesting that the effects of depression were significantly magnified by comorbid CI, and vice versa. VMPFC is responsible for context-appropriate emotional evaluation of events and stimuli, and reward processing ([@bb0075; @bb0335]). The DLPFC and the dorsal ACC play key roles in conflict monitoring, error detection, response selection and mediating executive functions ([@bb0030]). While the findings in the MOG are intriguing, hypoperfusion in the primary visual cortices is seen in aMCI, and is one of the brain areas that accurately discriminate AD from controls in R-fMRI studies ([@bb0090; @bb0095]). In these interactive brain regions, when LLD and nondepressed aMCI subjects demonstrated decreased functional connectivity, patients with coexisting LLD and aMCI showed significantly enhanced connections. These findings were present despite the fact that the comorbid group demonstrated comparable levels of depression severity as the LLD-only group and a similar degree of cognitive deficits as the nondepressed aMCI subjects.

The coexistence of subclinical and syndromal LLD with aMCI is associated with greater gray and white matter atrophy, cognitive decline and conversion to AD ([@bb0190; @bb0230; @bb0375]). In individuals at-risk for AD, increased functional connectivity and increased activation to memory tasks in the prefrontal and MTL regions have been hypothesized as compensatory recruitment of neural resources to maintain adequate cognitive performance or a transient phase that represent impending failure of neuronal networks ([@bb0315]). For instance, greater hippocampal activation predicted those individuals with aMCI at highest risk for subsequent cognitive decline in one study ([@bb0225]). Major depression also has been associated with increased DMN and affective network functional connectivity ([@bb0035; @bb0160; @bb0295]). Taken together, our data may reflect a compensatory process whereby the comorbid group is recruiting additional neural resources to improve cognitive functions, a transient response of a failing functional network and/or an effect of the depressed state.

4.4. Neural correlates of the effects of depressive symptoms and episodic memory on HFC networks {#s0115}
------------------------------------------------------------------------------------------------

Greater depressive symptom severity was associated with mostly increased positive and anticorrelated HFC bilaterally in several frontal, parietal and temporal areas, which are consistent with our previous results ([@bb0145]) as well as the LLD group findings. The DLPFC, inferior parietal, frontal opercular and insular cortices, which are regions associated with executive control, attentional and salience processing, were functionally anticorrelated to the hippocampus (i.e., blue color in these regions represent increased anticorrelations being related to greater depressive symptom severity) ([Fig. 4](#f0020){ref-type="fig"}A top row). In contrast, increased hippocampal-DLPFC connectivity was associated with greater depressive symptom severity, after regressing out the subject group effects. These results suggest that the diminished hippocampal-DLPFC functional connections seen in LLD may be a disorder-specific phenomenon.

We also found positive correlations between HFC and LMII-DR in the medial prefrontal and inferior temporal cortices, and thalamus (i.e., increased hippocampal connections were related to better episodic memory performance) ([Fig. 4](#f0020){ref-type="fig"}A middle row). However, we found an opposite relationship where poorer memory was associated with increased hippocampal connections in the sensorimotor, precuneus and the MTL regions, which are contrary to the aMCI group findings. It is possible that older adults with poorer episodic memory compensate by enhancing functional connections in these regions. An alternative explanation is that decreased MTL and posterior default mode functional connections are specific to the neurodegenerative disease-state. The differences in sample sizes, inclusion/exclusion criteria and the HFC assessments separately (versus combined in the previous study ([@bb0145]) may also have contributed to the discrepancies.

The GDS and LMII-DR interactive effects on the HFC in the default mode, fronto-parietal and salience regions ([Fig. 4](#f0020){ref-type="fig"}A bottom row) are similar to our prior findings ([@bb0145]). Future studies that examine the HFC alterations specific to different affective and cognitive disorders versus dimensional measures should be conducted.

4.5. Potential pathophysiological mechanisms {#s0120}
--------------------------------------------

LLD may share common pathophysiologic mechanisms with aMCI and AD. Patients with remitted geriatric depression that met aMCI criteria had cortical amyloid accumulation comparable to that seen in AD ([@bb0085]). Significantly higher amyloid and tau deposition in the PCC and temporal lobes in symptomatic individuals with LLD were recently reported ([@bb0175]). Other mechanisms may be shared between LLD and aMCI, including subclinical cerebrovascular disease, genetic variations, proinflammatory cytokines and oxidative stress ([@bb0170; @bb0235]). Separate mechanisms may differentially contribute to the abnormal hippocampal functional integrity when LLD and aMCI occur alone. However, a multiple neurobiological vulnerabilities may be present in those with comorbidities that may lead to more pronounced HFC abnormalities and subsequent cognitive decline.

4.6. Limitations {#s0125}
----------------

First, we are unable to make firm conclusions if the increased HFC in the comorbid group reflects a compensatory process of a failing network and/or an effect of the depressed state. Longitudinal studies are essential to elucidate this hypothesis. Second, the sample in the comorbid group is relatively small, and our results need to be replicated in larger studies. Third, an ideal study design would be to include antidepressant-free participants to eliminate potential confounding effects. However, since the majority of our depressed participants had failed at least one therapeutic antidepressant trial and had moderate-to-severe depression (LLD only: N = 9; comorbid group: N = 10), the ethical aspects restricted us from performing such a study. Similarly, while acetylcholinesterase inhibitors (ChEI) and memantine are not approved for treatment of aMCI, physicians commonly prescribe these medications off-label to those with aMCI with and without coexisting LLD ([@bb0215; @bb0260; @bb0265]). Therefore, as long as aMCI patients were on stable doses and the dosages were not expected to change during the study participation, cognitive enhancer use was allowed. Fourth, although we excluded subjects with unstable medical conditions and all participants had to score within the normal range on the modified HIS, varying levels of cerebrovascular and chronic medical disease burden across groups may have influenced our findings.

5. Conclusions {#s0130}
==============

In conclusion, discrete HFC abnormalities were associated with LLD and aMCI, whereas interplay between these syndromes was present in the hippocampal network level involving hubs of the commonly described intrinsic resting-state networks. Interestingly, these differences were predominantly driven by differences between the comorbid and other subject groups. Future R-fMRI studies should determine changes in the hippocampal functional connectivity over time in LLD patients with and without aMCI, as it relates to the risk of future cognitive decline and incident dementia.

The following are the supplementary data related to this article.Fig. S1Whole-brain voxelwise pattern of the left hippocampal functional connectivity (LHFC) networks in the four group subjects (*p* \< 0.01, AlphaSim correction). Bright color indicates positive connectivity and blue color indicates negative or anticorrelated connectivity. Color bar is presented with *z* scores. Abbreviation: CN, control; Dep, depression; aMCI, amnestic mild cognitive impairment; dMCI, depressed mild cognitive impairment.Fig. S2Whole-brain voxelwise pattern of the right hippocampal functional connectivity (RHFC) networks in the four subject groups (*p* \< 0.01, AlphaSim correction). Bright color indicates positive connectivity and blue color indicates negative or anticorrelated connectivity. Color bar is presented with *z* scores. Abbreviation: CN, cognitively normal; Dep, depression; aMCI, amnestic mild cognitive impairment; dMCI, depressed mild cognitive impairment.Supplementary material.
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![Main effects of depression and mild cognitive impairment on the left hippocampal functional connectivity (LHFC) networks across all subjects (*p* \< 0.05, AlphaSim correction). Left: Brain regions with significant main effects of depression and cognitive impairment on the LHFC network. Bright color indicates increased connectivity and blue color indicates decreased connectivity. Color bar is presented with *z* scores. Right: Numerical representation of significant main effects of depression and mild cognitive impairment on the LHFC network (m is *z* value from the cross-correlation coefficient after Fisher\'s *z* transformed, same below). Abbreviations: Non-Dep: no depression; Dep: depression; Non-CI: no amnestic mild cognitive impairment; CI: amnestic mild cognitive impairment. R1: left posterior cingulate cortex/precuneus (LPCC/Pcu); R2: right posterior cingulate cortex/precuneus (RPCC/Pcu); R3: right dorsomedial prefrontal cortex (RDMPFC); R4: right dorsolateral prefrontal cortex (RDLPFC); R5: left dorsolateral prefrontal cortex (LDLPFC); R6: left postcentral gyrus; R7: left inferior parietal cortex (LIPC); R8: left posterior middle temporal gyrus (LpMTG); R9: left dorsomedial prefrontal cortex (LDMPFC); R10: left retrosplenial cortex (LRSC); R11: right inferior parietal cortex (RIPC); R12: right superior parietal cortex (RSPC); R13: right dorsolateral prefrontal cortex (RDLPFC); R14: right dorsomedial prefrontal cortex (RDMPFC); R15: right dorsal cingulate cortex (RdACC); R16: right retrosplenial cortex (RRSC). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr1){#f0005}

![Main effects of depression and mild cognitive impairment on the right hippocampal functional connectivity (RHFC) networks across all subjects (*p* \< 0.05, AlphaSim correction). Left: Brain regions with significant main effects of depression and mild cognitive impairment on the RHFC network. Bright color indicates increased connectivity and blue color indicates decreased connectivity. Color bar is presented with *z* scores. Right: Numerical representation of significant main effects of depression and mild cognitive impairment on the RHFC network. Abbreviations: Non-Dep: no depression; Dep: depression; Non-CI: no amnestic mild cognitive impairment; CI: amnestic mild cognitive impairment. R1: left dorsolateral prefrontal cortex (LDLPFC); R2: left middle occipital gyrus (LMOG); R3: left hippocampus; R4: left thalamus; R5: left putamen; R6: left caudate; R7: right lentiform nucleus; R8: right thalamus; R9: right middle occipital gyrus (RMOG); R10: left ventrolateral prefrontal cortex (LvlPFC); R11: left anterior temporal pole (LaTP); R12: left inferior parietal cortex (LIPC); R13: left posterior middle temporal gyrus (LpMTG); R14: right supramarginal gyrus/inferior parietal cortex; R15: right anterior temporal pole (RaTP); R16: left parahippocampal gyrus (LPHG); R17: right inferior temporal cortex (RITG). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr2){#f0010}

![Interactive effects of late-life depression and amnestic mild cognitive impairment on the right hippocampal functional connectivity (RHFC) networks (*p* \< 0.05, AlphaSim correction). Top: Brain regions with significant interactive effects between late-life depression and mild cognitive impairment on the RHFC network. Bottom: Numerical representation of significant interactive effects of depression and cognitive impairment on the RHFC network. \*: *p* \< 0.05; \*\*: *p* \< 0.01. Abbreviations: LMOG, left middle temporal gyrus; LdACC, left dorsal cingulate cortex; vmPFC, ventromedial prefrontal cortex; RdACC, right dorsal cingulate cortex; RMOG, right middle temporal gyrus; RDLPFC, right dorsolateral prefrontal cortex; RvmPFC, right vmPFC; LvmPFC, left vmPFC; CN, cognitively normal; aMCI, amnestic mild cognitive impairment; Dep, Late-life depression; dMCI, comorbid late-life depression and amnestic mild cognitive impairment.](gr3){#f0015}

![Behavioral significance of the bilateral hippocampal functional connectivity networks across all subjects (*p* \< 0.05, AlphaSim correction). Top row: Main effects of the depressive symptoms on the bilateral HFC networks; Middle row: Main effects of the episodic memory scores (LMIIDR scores) on the bilateral HFC networks. Bright color indicates positive correlation and blue color indicates negative correlation; Bottom row: Interaction of depressive symptoms and memory function on the bilateral HFC networks. Bright color indicates that the interactive effects are positively correlated with bilateral HFC; blue color demonstrates that the interactive effects are negatively correlated with bilateral HFC. Color bar is presented with *z* scores.\
Abbreviations: GDS, geriatric depression scale; LHFC, left hippocampal functional connectivity; RHFC, right hippocampal functional connectivity; LDLPFC, left dorsolateral prefrontal cortex; RDLPFC, right dorsolateral prefrontal cortex; LDMPFC, left dorsomedial prefrontal cortex; RDMPFC, right dorsomedial prefrontal cortex; LITC, left inferior temporal cortex; RITC, right inferior temporal cortex; LHip/PHG, left hippocampus/parahippocampal gyrus; RHip/PHG, right hippocampus/parahippocampal gyrus; LIPC, left inferior parietal cortex; RIPC, right inferior parietal cortex; LaI/fO, left anterior insula/frontal operculum; RaI/fO, right anterior insula/frontal operculum; LIFG, left inferior frontal gyrus; LTha, left thalamus; L Pcu/PCG, precuneus/postcentral gyrus; Pcu/PCG, precuneus/postcentral gyrus; vmPFC, ventromedial prefrontal cortex; Amy/PHG, amygdala/parahippocampal gyrus; RpMTG, right posterior middle temporal gyrus. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr4){#f0020}

###### 

Demographic and neuropsychiatric characteristics.

  ---------------------------------------------------------------------------------------------------------------------------------------
                                      CN\        Dep\       aMCI\       aMCI/Dep\   *p*-Value                                
                                      (n = 25)   (n = 18)   (n = 17)    (n = 12)                                             
  ----------------------------------- ---------- ---------- ----------- ----------- ------------ ------ ------------ ------- ------------
  Age (year)                          74.28      8.25       68.61^a^    6.81        75.12^d^     6.62   68.33^f^     13.87   0.043^Ϯ^

  Education (years)                   15.32      2.87       14.61       2.57        13.47        2.07   14.25        2.99    0.175

  Gender (F/M)                        12/13      14/4       11/6        7/5         0.135                                    

                                                                                                                             

  *Neuropsychological measures*                                                                                              

  MMSE                                28.92      1.22       28.06       1.21        27.29        1.83   26.92^c^     1.93    0.001\*

  DRS-2 raw scores                                                                                                           

   Attention                          36.56      0.51       36.39       0.70        35.71^b^     0.77   36.00        1.21    0.004\*

   INIT/PERS                          36.32      1.38       36.22       2.10        34.88        3.62   32.50        5.55    0.005

   Construct                          6.00       0.00       5.94        0.24        5.94         0.24   5.83         0.58    0.436

   Conceptual                         37.76      1.33       37.61       1.24        35.88^b^     2.45   35.41^ce^    3.12    0.001\*

   Memory                             23.64      1.04       23.89       1.13        19.06^bd^    2.68   19.50^ce^    3.60    \< 0.001\*

   Total                              140.36     2.53       140.11      3.20        130.88^bd^   5.49   129.67^ce^   6.70    \< 0.001\*

  Recall scores                                                                                                              

   IMMED                              14.36      3.73       14.17       3.96        8.41^bd^     3.59   7.17^ce^     3.76    \< 0.001\*

   DELAYED                            12.92      4.03       12.06       4.24        2.47^bd^     3.30   3.25^ce^     3.14    \< 0.001\*

  HAMA                                1.16       1.06       10.88^a^    5.07        2.18^d^      1.55   8.67^cf^     4.19    \< 0.001\*

  GDS                                 1.88       2.11       17.28^a^    3.29        4.35^d^      2.67   14.25^cf^    6.43    \< 0.001\*

                                                                                                                             

  *Current antidepressants (%)*                                                                                              

  No antidepressant                   --         2 (11.1)   16 (94.1)   2 (16.7)                                             

  SSRI monotherapy                    --         2 (11.1)   1 (5.9)     2 (16.7)                                             

  SNRI monotherapy                    --         4 (22.2)   --          2 (16.7)                                             

  Other                               --         2 (11.1)   --          1 (8.3)                                              

  Combination therapy                 --         8 (44.5)   --          5 (41.6)                                             

                                                                                                                             

  *Current cognitive enhancers (%)*                                                                                          

  No cognitive enhancers              --         --         8 (47.1)    8 (66.6)                                             

  ChEI monotherapy                    --         --         7 (41.1)    2 (16.7)                                             

  Memantine monotherapy               --         --         1 (5.9)     2 (16.7)                                             

  Combination therapy                 --         --         1 (5.9)     --                                                   
  ---------------------------------------------------------------------------------------------------------------------------------------

Notes: In demographic information, age showed significant across the subject groups without corrections for multiple comparisons (Ϯ: *p* \< 0.05). In addition, significant differences (\*: *p* \< 0.0045, Bonferroni correction for multiple comparison) were found in MMSE, DRS-2 raw scores (except for INIT/PERS and Construct), memory recalled scores (IMMED and Delayed) and emotional scores (HAMA and GDS) among four groups. a--f: post-hoc analysis further revealed the source of ANOVA difference (a: CN vs Dep; b: CN vs aMCI; c: CN vs aMCI/Dep; d: Dep vs aMCI; e: Dep vs aMCI/Dep; f: aMCI vs aMCI/Dep). Unless otherwise indicated, data are presented as mean ± SD. Abbreviation: CN, cognitive normal or controls; Dep, depression; aMCI, amnestic mild cognitive impairment; aMCI/Dep, amnestic mild cognitive impairment with depression; M, mean; SD, standard deviation; F/M: female/male; MMSE, mini-mental state examination; DRS-2: dementia rating scale-2; INIT/PERS: Initiation/Preservation; IMMED, immediate recall scores; DELAYED, delayed recall scores; HAMA, Hamilton anxiety scales scores; GDS, geriatric depression scale scores; SSRI: selective serotonin re-uptake inhibitors; SNRI: serotonin norepinephrine re-uptake inhibitors; ChEI: cholinesterase inhibitors. Other antidepressants include: bupropion, mirtazapine, and trazodone.
